Press Releases
-
Acroscell Offers Cardiac Ion Channel Screen Panels to Detect and Analyze Effects of Candidate Drugs
Dec 27, 2021
-
Creative Bioarray Develops State-of-art Cell Based Assay to Support Biomedical Research and Drug-discovery Process
Dec 27, 2021
-
Microbialtec Platform Develops Chemotaxonomy-based Drug Discovery to Accelerate The Development of Drug Discovery
Dec 27, 2021
-
IntegrateRNA Develops One-stop Solutions for Oligonucleotide Conjugation Services to Facilitate Diagnostic and Targeted Drug Delivery
Dec 27, 2021
-
Microbiosci Offers Reliable Strain Selection and Fermentation Services to Suit The Needs of Microbial Research
Dec 27, 2021
-
Certified Reference Materials for Chromatography Are Now Available at Alfa Chemistry
Dec 27, 2021
-
BOC Sciences Promotes Drug Development by Pharmaceutical Impurity Identification
Dec 27, 2021
-
CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions
Dec 28, 2021
-
CD Formulation Optimizes Elemental Impurities Analysis Service
Dec 29, 2021
-
Biotium Introduces Unique Super-Sensitive RNA Prestain Loading Dye
Biotium has announced the release of EMBER500™ RNA Prestain Loading Dye.
Jan 4, 2022
-
Emmes Acquires Institut Dr. Schauerte
Jan 4, 2022
-
WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site
Jan 5, 2022
-
WuXi STA Forms Strategic Partnership with Coherent Biopharma
Dec 1, 2021
-
Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19
Dec 1, 2021
-
Sensyne Health and Cambridge University Hospitals NHS Foundation Trust Sign Strategic Research Agreement
Research will focus on CUH’s areas of disease expertise and specialism in cancer, cardiovascular disease and rare diseases New agreement covers 3 million patient records and brings the combined total of de-identified patient data directly accessible for medical research to 25.5 million patients
Dec 2, 2021
-
DFE Pharma researcher recognized as one of the 2021 Outstanding Early Career Scientists
Dec 5, 2021
-
CluePoints Wins Scrip Award for Clinical Advance of the Year 2021
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category - COVID-19 Pandemic Special Recognition Award at the 17th Annual Scrip Awards.
Dec 5, 2021
-
Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022
Over 25,000 online and 23,000 in person attendees at the world’s largest pharma trade exhibition
Nov 24, 2021
-
BaseClear announces the appointment of Dr. Alex van Belkum as Chief Scientific Officer (CSO), effective December 1, 2021
BaseClear has announced the appointment of Dr. Alex Van Belkum as Chief Scientific Officer (CSO).
Nov 28, 2021
-
ProRelix Research LLC starts clinical trial operations in USA to conduct multi country clinical trials
Nov 29, 2021


